Daxor Price to Sales Ratio 2010-2011 | DXR
Historical PS ratio values for Daxor (DXR) over the last 10 years. The current P/S ratio for Daxor as of June 27, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Daxor P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-06-28 | 9.32 | 27.21 | |
| 2011-12-31 | 8.64 | $0.34 | 25.23 |
| 2011-09-30 | 9.93 | $0.34 | 29.18 |
| 2011-06-30 | 9.57 | $0.37 | 26.11 |
| 2011-03-31 | 9.51 | $0.37 | 25.80 |
| 2010-12-31 | 8.58 | $0.37 | 23.03 |
| 2010-09-30 | 8.00 | $0.39 | 20.28 |
| 2010-06-30 | 8.55 | $0.38 | 22.22 |
| 2010-03-31 | 9.50 | $0.39 | 24.52 |
| 2009-12-31 | 10.15 | $0.40 | 25.68 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.046B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.643B | 10.07 |
| Quest Diagnostics (DGX) | United States | $15.257B | 15.77 |
| DaVita (DVA) | United States | $12.405B | 15.41 |
| Encompass Health (EHC) | United States | $8.645B | 22.13 |
| Chemed (CHE) | United States | $8.250B | 25.57 |
| Elanco Animal Health (ELAN) | United States | $7.052B | 18.30 |
| Option Care Health (OPCH) | United States | $4.858B | 18.39 |
| RadNet (RDNT) | United States | $4.352B | 90.61 |
| Amedisys (AMED) | United States | $3.038B | 21.52 |
| Astrana Health (ASTH) | United States | $2.284B | 30.89 |
| Addus HomeCare (ADUS) | United States | $1.870B | 26.75 |
| LifeStance Health (LFST) | United States | $1.866B | 0.00 |
| U.S Physical Therapy (USPH) | United States | $1.403B | 37.55 |
| Pennant (PNTG) | United States | $0.682B | 36.05 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.492B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.221B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.020B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.015B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.003B | 0.00 |